Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advanced BioScience Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011794
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract research and manufacturing company that provides services to life sciences industry. The company develops vaccines, therapeutics and other biologic products. It provides proof-of-concept in vivo studies with preclinical immunomonitoring, potency testing and efficacy. ABL’s services include technology transfer, upstream cell culture, and others. The company offers contract research services and contract manufacturing services, which include virus seed stock development, plaque purification, cGMP virus banking, viral lysate production, upstream process development, downstream purification development, production of toxicology supply and production of clinical supply. ABL is headquartered in Rockville, Maryland, the US.

Advanced BioScience Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Advanced BioScience Labs Acquires Production Asset of Transgene 10
Partnerships 11
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Asset Transactions 13
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc – Key Competitors 15
Advanced BioScience Laboratories Inc – Key Employees 16
Advanced BioScience Laboratories Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
May 11, 2017: ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line 18
Government and Public Interest 19
Jul 26, 2016: The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support 19
Mar 03, 2016: ABL Part of Team Awarded $900 Million IDIQ Contract by U.S. Army for Medical Product Research and Development 20
Other Significant Developments 21
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Labs Acquires Production Asset of Transgene 10
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc, Key Competitors 15
Advanced BioScience Laboratories Inc, Key Employees 16
Advanced BioScience Laboratories Inc, Subsidiaries 17

★海外企業調査レポート[Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangxi Nonferrous Metals Group Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Guangxi Nonferrous Metals Group …
  • Corvia Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc is a medical device company that offers structural heart disease solutions. The company develops interatrial shunt device (IASD), a trans-catheter device designed diastolic heart failure, also known as heart failure with preserved ejection …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    SummaryOglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • UniPro Foodservice Inc.:企業概要およびSWOT分析
    Summary Canadean's "UniPro Foodservice Inc.: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company his …
  • InfoSonics Corporation (IFON):企業の財務及び戦略的SWOT分析
    Summary InfoSonics Corporation (InfoSonics) is a telecommunications equipment manufacturer that develops, manufactures, and distributes wireless handsets and other wireless solutions. The company’s products include phones, cell phones, mobile phones, feature phones and smartphones and accessories. I …
  • The Madison Square Garden Company:企業の戦略・SWOT・財務分析
    SummaryThe Madison Square Garden Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lavasa Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lavasa Corporation Limited Merg …
  • Sayaji Hotels Limited:企業の戦略・SWOT・財務分析
    SummarySayaji Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and markets intradermal delivery solutions for vaccines and drugs. The company offers product such as MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its products are used wit …
  • Zecon Berhadの企業概要及び財務/SWOT分析
    Zecon Berhad Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Zecon Berhad annual and quarterly forecasts made by stock market experts. The report also enables direct comparis …
  • Ithmaar Bank B.S.C.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ithmaar Bank B.S.C. Mergers and …
  • Teradyne, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Teradyne, Inc. Mergers and Acqu …
  • Applied Materials, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Applied Materials, Inc. Mergers …
  • Linklaters LLP:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Linklaters LLP" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a …
  • Black Hills Energy:企業のM&A・提携動向(エネルギー分野)
    Summary Black Hills Energy (BHE), a subsidiary of Black Hills Corporation, is a utility service provider that provides electricity and natural gas service to its members. The company offers service such as installation, repair, operation and maintenance. Its installation and repair services include …
  • Fagron N.V. (FAGR):企業のM&A・提携動向(医療機器分野)
    Summary Fagron N.V. (Fagron) formerly Arseus NV, is a scientific pharmaceutical research and development (R&D) company that provides pharmaceutical compounding solutions. The company provides compounding essentials, trademarks, and pharma services to pharmacies, hospitals and clinics worldwide. Fagr …
  • Resource America, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Resource America, Inc. Mergers …
  • Netcare Limited (NTC):企業概要、財務及び戦略的SWOT分析
    Summary Netcare Limited (Netcare) is a healthcare service provider. It provides patient care and medical facilities. The center offers treatments, facilities and transplants. Netcare provides treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight managemen …
  • PT. Bank Negara Indonesia (Persero) Tbk.:企業の戦略・SWOT・財務分析
    SummaryPT. Bank Negara Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆